Yong-Kang Zhang

This inventor holds 60 USPTO granted patents and 27 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Boron-Containing Compounds (CPC class A61K). Top assignees: Anacor Pharmaceuticals, Inc., Centaur Pharmaceuticals, Inc., 5Metis, Inc.. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong-Kang Zhang. Retrieved from https://idiyas.com/inventor/yong-kang-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 60 (Patent Applications = 27)

% Patents Active = 76.7

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 12 (Patent Applications = 16)

Average Co-Inventor Count = 6.5

ph-index = 16

Forward Citations = 816(Granted Patents)

Forward Citations (Not Self Cited) = 602(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Santa Clara, CA (US) (1999 - 2002)
Moraga, CA (US) (2015 - 2017)
San Jose, CA (US) (2002 - 2023)
Cary, NC (US) (2021 - 2023)

Company Filing History:

37 out of 70

Anacor Pharmaceuticals, Inc.

patents

12 out of 35

Centaur Pharmaceuticals, Inc.

Bill & Melinda Gates Foundation

Eli Lilly and Company

Johnson & Johnson Consumer Companies, Inc.

patents

9. 1 out of 11

Mmv Medicines for Malaria Venture

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Benzoxaborole Compounds

Boron-Containing Molecules

Oxaborole Esters

Antiprotozoal Agents

Anti-Inflammatory Agents

Hydrolytically-Resistant

Chemical Compounds

Substituted Benzoxaborole

Therapeutics

Formulations

Ectoparasite Control

Small Molecules

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358932 - Chemical compounds (2025-07-15),

2. 12098159 - Solid forms of substituted benzoxaborole and compositions thereof (2024-09-24),

3. 11834466 - Benzoxaborole compounds and formulations thereof (2023-12-05),

4. 11578087 - Oxaborole esters and uses thereof (2023-02-14),

5. 11560393 - Solid forms of substituted benzoxaborole and compositions thereof (2023-01-24),

6. 11306108 - Chemical compounds (2022-04-19),

7. 11236115 - Solid forms of substituted benzoxaborole and compositions thereof (2022-02-01),

8. 11066424 - Solid forms of substituted benzoxaborole and compositions thereof (2021-07-20),

9. 10919916 - Boron-containing small molecules (2021-02-16),

10. 10882872 - Oxaborole esters and uses thereof (2021-01-05),

11. 10611780 - Boron-containing small molecules (2020-04-07),

12. 10562921 - Oxaborole esters and uses thereof (2020-02-18),

13. 10533021 - Boron-containing small molecules (2020-01-14),

14. 10011616 - Boron-containing small molecules as antiprotozoal1 agents (2018-07-03),

15. 9796735 - Boron-containing small molecules (2017-10-24),

Title: Innovations and Contributions of Yong-Kang Zhang

Introduction

Yong-Kang Zhang is a prolific inventor based in San Jose, CA, recognized for his innovative contributions in the field of pharmaceuticals. With an impressive portfolio of 59 patents, Zhang has made significant strides in advancing drug formulations and treatments that address various pathogens.

Latest Patents

His latest patents include groundbreaking work on solid forms of substituted benzoxaborole compounds. This invention discusses the crystalline forms of a specific compound and its applications in medical compositions. Another notable patent details a benzoxaborole formulation that combines a benzoxaborole compound with a mixture of surfactants and carriers. This formulation is designed to combat a range of pathogens, including insects, bacteria, and fungi, showcasing Zhang's commitment to addressing complex biological challenges.

Career Highlights

Zhang has held pivotal roles in recognized organizations, notably Anacor Pharmaceuticals and Centaur Pharmaceuticals. His work has been fundamental in the development of novel pharmaceuticals, contributing to improved therapies in the industry. His extensive patent portfolio highlights his expertise and innovative approach within the pharmaceutical sector.

Collaborations

Throughout his career, Zhang has collaborated with talented individuals such as Jacob J. Plattner and Tsutomu Akama. These partnerships have enriched his research and development efforts, fostering creativity and innovation in pharmaceutical sciences.

Conclusion

Yong-Kang Zhang’s contributions to the field of patents and innovations in drug formulations demonstrate the significant impact of dedicated inventors. His work continues to play a crucial role in advancing medical treatments, reflecting his commitment to innovation and excellence in research.

Profile summary based on public USPTO records.